According to the American Cancer Society, one in two men and one in three women will get cancer in their lifetime. But research in molecular imaging could help physicians detect cancer before symptoms appear and monitor treatment more effectively.

Thanks to advanced imaging technologies such as PET•CT and SPECT•CT, researchers can see the tiniest abnormalities in cells that previously would have gone undetected in patients until a cancer was at a more advanced, harder to treat stage. This early detection provides a better opportunity for successful treatment. The five-year survival rate of a vast majority of cancers is over 90 percent when detected in Stage 1, according to Ralph Weissleder, M.D., Ph.D., director, Center for Molecular Imaging Research.

NOTE: The streaming audio and video files below require Microsoft© Windows Media© Player.

  Siemens on TV: Detecting Cancer Through Molecular Imaging, Windows Media Player for DSL/Cable/T1[13.43 MB]